On May 25, 2023, the company has received $149,999,801 in its first tranche. The transaction was led by returning investor, Deep Track Capital, LP and included participation from new investors, 5AM Venture Management, LLC, Franklin Resources, Inc., Frazier Life Sciences Management, LP, Janus Henderson Group plc, Millennium Management LLC, TCG Crossover Management, LLC, Venrock Healthcare Capital Partners Fund, L.P., fund managed by VR Adviser, LLC and returning investors, RA Capital Management, L.P., The Column Group LLC, Willett Advisors LLC. The transaction included participation from 25 investors pursuant to exemption provided under Regulation D. The transaction was oversubscribed.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.68 USD | +0.69% | -3.31% | +1.76% |
Apr. 12 | UBS Adjusts Janus Henderson Group Price Target to $30 From $28, Maintains Sell Rating | MT |
Apr. 02 | Goldman Sachs Raises Janus Henderson's Price Target to $32 From $29, Keeps Sell Rating | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
30.68 USD | +0.69% | -3.31% | 4.91B | ||
25.15 USD | +0.52% | -1.02% | 13.17B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.76% | 4.91B | |
-7.62% | 111B | |
-1.53% | 90.88B | |
+15.14% | 60.96B | |
+0.88% | 58.51B | |
+9.79% | 41.34B | |
+8.15% | 41.32B | |
+17.10% | 34.21B | |
+0.97% | 24.31B | |
-5.28% | 22.02B |
- Stock Market
- Equities
- JHG Stock
- News Janus Henderson Group plc
- Carmot Therapeutics, Inc. announces tranche update